1. Detecting bradykinesia in early morning "OFF" episodes: a large database study using the Personal KinetiGraph® (PKG®). (October 2020) Authors: Isaacson, S.; Pahwa, R.; Pappert, E.; Torres-Russotto, D. Journal: Parkinsonism & related disorders Issue: Volume 79(2020) Supplement 1 Page Start: e88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Duration of rimabotulinumtoxinB action in the treatment of adult sialorrhea. (October 2020) Authors: Pagan, F.; Lew, M.; Pahwa, R.; Clinch, T.; Kasibhatla, C.; Isaacson, S. Journal: Parkinsonism & related disorders Issue: Volume 79(2020) Supplement 1 Page Start: e60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in subjects with Parkinson's disease: preliminary results from the Phase-3 study dose-titration phase. (January 2018) Authors: Espay, A.J.; Hauser, R.A.; Isaacson, S.; Pahwa, R.; Truong, D.; Pappert, E.; Agro, A.; Fernandez, H.H. Journal: Parkinsonism & related disorders Issue: Volume 46(2018)Supplement 2 Page Start: e19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evaluation of morning bradykinesia in Parkinson's disease in a United States cohort using continuous objective monitoring. (2022) Authors: Isaacson, S.H.; Pahwa, R.; Pappert, E.J.; Torres-Russotto, D. Journal: Clinical parkinsonism & related disorders Issue: Volume 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Onset of action for rimabotulinumtoxinB in the treatment of adult sialorrhea. (October 2020) Authors: Bahroo, L.; Lew, M.; Pahwa, R.; Clinch, T.; Kasibhatla, C.; Isaacson, S. Journal: Parkinsonism & related disorders Issue: Volume 79(2020) Supplement 1 Page Start: e56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pooled analysis of phase 3 studies of ADS-5102 for levodopa-induced dyskinesia: A detailed review of MDS-UPDRS, part IV (motor complications). (January 2018) Authors: Tanner, C.; Pahwa, R.; Elmer, L.; Isaacson, S.; Johnson, R.; Felt, L.; Patni, R. Journal: Parkinsonism & related disorders Issue: Volume 46(2018)Supplement 2 Page Start: e20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety of sublingual apomorphine film (APL-130277) for the treatment of OFF-episodes in subjects with Parkinson's disease: preliminary results from the Phase-3 study dose titration phase. (January 2018) Authors: Fernandez, H.H.; Isaacson, S.; Espay, A.J.; Pahwa, R.; Truong, D.; Pappert, E.; Agro, A.; Hauser, R.A. Journal: Parkinsonism & related disorders Issue: Volume 46(2018)Supplement 2 Page Start: e82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Study design and rationale for an international study of DBS for movement disorders. (October 2020) Authors: Pahwa, R.; Pilitsis, J.; Groppa, S.; Fasano, A.; Ostrem, J.; Phibbs, F.; Lyons, K.; Jimenez-Shahed, J.; Pouratian, N.; Neimat, J.; Defresne, F.; Karst, E.; Cheeran, B.; Schnitzler, A. Journal: Parkinsonism & related disorders Issue: Volume 79(2020) Supplement 1 Page Start: e17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗